Shares of Amag Pharmaceuticals climbed 45.2% on Thursday after the company approved a takeover bid by Covis Pharma. The transaction is expected to be completed in November this year. Covis will pay ...

Apollo Global Management has agreed to acquire Covis Pharma from Cerberus Capital Management. No financial terms were disclosed. Rothschild & Co is the financial advisor to Covis and Cerberus on the ...

Covis, which is backed by Apollo Global Management, has agreed to acquire AMAG Pharmaceuticals for $13.75 per share in cash. Goldman Sachs is serving as financial advisor to AMAG. Based in Waltham, ...

WOBURN, Mass., March 14, 2025 /CNW/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing investors. With ...

Covis Group S.à r.l. (Covis) and AMAG Pharmaceuticals, Inc. announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 per share in cash, or ...

Deal to acquire Covis is expected to expand Azurity’s portfolio across multiple complex dosage forms and key therapeutics areas. Azurity Pharmaceuticals has completed its acquisition of Covis Pharma, ...